|
Sept. 11, 2024 |
|
|
Feb. 04, 2025 |
|
|
jRCT2022240022 |
Exploratory Trial of NP039 for Thoracic Aortic Replacement |
|
Exploratory Trial of NP039 for Thoracic Aortic Replacement |
Nishibata Nozomi |
||
NIPRO CORPORATION |
||
3023, Nojicho, Kusatsu, Shiga |
||
+81-77-564-9467 |
||
nishibata-nozomi@nipro.co.jp |
||
Nishibata Nozomi |
||
NIPRO CORPORATION |
||
3023, Nojicho, Kusatsu, Shiga |
||
+81-77-564-9467 |
||
nishibata-nozomi@nipro.co.jp |
Recruiting |
Dec. 01, 2024 |
||
| 40 | ||
Interventional |
||
randomized controlled trial |
||
single blind |
||
active control |
||
parallel assignment |
||
treatment purpose |
||
-Written informed consent from patients or legal representative if patients lack of ability to consent. |
||
1. emergency surgery patients |
||
| 18age old over | ||
| No limit | ||
Patients with vascular anastomoses that may not achieve hemostasis by ligation or normal surgical pr |
||
The anastomosis will be reinforced with the investigational device NP039 or the control device by random assignment and the examinations and observations specified in the protocol will be performed. |
||
Reinforcement success rate per case |
||
| NIPRO CORPORATION |
| Tohoku University Hospital Institutional Review Board | |
| 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan, Miyagi | |
+81-22-717-7000 |
|
| chiken@chiken.hosp.tohoku.ac.jp | |
| Not approval |
No |
none |